| Secondary |
| Renal Transplant |
14.3% |
| Product Used For Unknown Indication |
13.3% |
| Immunosuppression |
8.1% |
| Drug Use For Unknown Indication |
7.2% |
| Rheumatoid Arthritis |
7.2% |
| Crohn's Disease |
7.1% |
| Prophylaxis Against Graft Versus Host Disease |
5.1% |
| Liver Transplant |
4.1% |
| Asthma |
3.6% |
| Juvenile Arthritis |
3.3% |
| Mantle Cell Lymphoma |
3.3% |
| Colitis Ulcerative |
3.1% |
| Heart Transplant |
2.9% |
| Bone Marrow Conditioning Regimen |
2.9% |
| Histoplasmosis |
2.9% |
| Psoriasis |
2.7% |
| Hypertension |
2.5% |
| Hiv Infection |
2.4% |
| Prophylaxis |
2.3% |
| Arthritis |
1.8% |
|
| Osteonecrosis |
8.3% |
| Weight Increased |
7.9% |
| Death |
7.5% |
| Post Procedural Urine Leak |
6.6% |
| Premature Baby |
6.6% |
| Sepsis |
6.2% |
| Weight Decreased |
6.2% |
| Tendonitis |
5.4% |
| Vomiting |
5.0% |
| Renal Failure |
4.6% |
| Drug Ineffective |
4.1% |
| Graft Versus Host Disease |
4.1% |
| Urinary Tract Infection |
4.1% |
| Cytomegalovirus Gastrointestinal Infection |
3.7% |
| Herpes Zoster |
3.7% |
| Tuberculosis |
3.7% |
| Pneumonia |
3.3% |
| Amnesia |
2.9% |
| Diabetes Mellitus |
2.9% |
| Septic Shock |
2.9% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
32.0% |
| Product Used For Unknown Indication |
11.8% |
| Colorectal Cancer |
11.2% |
| Prophylaxis |
8.7% |
| Drug Use For Unknown Indication |
6.2% |
| Rheumatoid Arthritis |
4.7% |
| Crohn's Disease |
4.1% |
| Premedication |
3.2% |
| Psoriasis |
2.3% |
| Renal Transplant |
2.0% |
| Hypertension |
1.9% |
| Thrombocytopenia |
1.8% |
| Immunosuppression |
1.7% |
| Pain |
1.4% |
| Non-small Cell Lung Cancer |
1.3% |
| Colitis Ulcerative |
1.3% |
| Breast Cancer |
1.2% |
| Osteoporosis |
1.2% |
| Multiple Myeloma |
1.2% |
| Asthma |
1.0% |
|
| Death |
17.9% |
| Drug Ineffective |
12.6% |
| Thrombocytopenia |
11.9% |
| Therapeutic Response Decreased |
9.5% |
| Vomiting |
4.5% |
| Sepsis |
4.0% |
| Platelet Count Decreased |
3.7% |
| Weight Decreased |
3.6% |
| Pneumonia |
3.5% |
| Thrombosis |
3.0% |
| Osteonecrosis |
3.0% |
| Hospitalisation |
2.9% |
| Myelodysplastic Syndrome |
2.9% |
| Dermatitis Acneiform |
2.6% |
| Tooth Extraction |
2.6% |
| Respiratory Failure |
2.6% |
| Pyrexia |
2.5% |
| Pulmonary Embolism |
2.3% |
| Bone Marrow Reticulin Fibrosis |
2.1% |
| Renal Failure |
2.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
21.9% |
| Rheumatoid Arthritis |
15.6% |
| Product Used For Unknown Indication |
14.1% |
| Chronic Sinusitis |
9.4% |
| Gingivitis |
9.4% |
| Keratoplasty |
6.3% |
| Keratitis Herpetic |
3.1% |
| Lung Transplant |
3.1% |
| Osteoporosis |
3.1% |
| Aspergillosis |
1.6% |
| Back Disorder |
1.6% |
| Cataract |
1.6% |
| Convulsion |
1.6% |
| Fungal Infection |
1.6% |
| Headache |
1.6% |
| Liver Transplant |
1.6% |
| Migraine |
1.6% |
| Neuropathy Peripheral |
1.6% |
|
| Drug Interaction |
20.0% |
| Tendon Rupture |
20.0% |
| Osteoporosis |
13.3% |
| Stevens-johnson Syndrome |
13.3% |
| Grand Mal Convulsion |
6.7% |
| Liver Transplant Rejection |
6.7% |
| Overdose |
6.7% |
| Palpitations |
6.7% |
| Weight Decreased |
6.7% |
|
